Memorial Sloan Kettering’s new tower on East 67th Street will be 76 feet shorter than previously planned, the cancer center ...

This article is authored by Dr Robin Mendelsohn, MD, gastroenterologist, Memorial Sloan Kettering Cancer Center.

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, ...

CHICAGO -- Adding perioperative durvalumab (Imfinzi) to FLOT chemotherapy significantly improved event-free survival (EFS) ...

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

NYC for MSK Participating Locations NYC for MSK 2025 Over 100 Participating Locations NEW YORK, NY, UNITED STATES, May 29, 20 ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

Music therapy appeared as effective as first-line cognitive behavioral therapy for reduction of anxiety among cancer ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...